These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 31912151)
21. A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals. Tan TY; Tan AL; Tee NW; Ng LS Ann Acad Med Singap; 2008 Oct; 37(10):835-40. PubMed ID: 19037517 [TBL] [Abstract][Full Text] [Related]
23. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia. Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913 [TBL] [Abstract][Full Text] [Related]
24. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. Mokaddas EM; Al-Sweih NA; Khan ZU J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809 [TBL] [Abstract][Full Text] [Related]
25. In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates. Dong J; Liang G; Zheng H; Kan S; Song N; Zhang M; Liu W Mycoses; 2021 Jun; 64(6):651-655. PubMed ID: 33609301 [TBL] [Abstract][Full Text] [Related]
26. Fluconazole-Resistant Candida auris Is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses. Pathirana RU; Friedman J; Norris HL; Salvatori O; McCall AD; Kay J; Edgerton M Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158282 [No Abstract] [Full Text] [Related]
27. Emergence and circulation of azole-resistant Ceballos-Garzon A; Peñuela A; Valderrama-Beltrán S; Vargas-Casanova Y; Ariza B; Parra-Giraldo CM Front Cell Infect Microbiol; 2023; 13():1136217. PubMed ID: 37026059 [TBL] [Abstract][Full Text] [Related]
28. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606 [TBL] [Abstract][Full Text] [Related]
29. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. Du H; Bing J; Hu T; Ennis CL; Nobile CJ; Huang G PLoS Pathog; 2020 Oct; 16(10):e1008921. PubMed ID: 33091071 [TBL] [Abstract][Full Text] [Related]
37. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health. Brilhante RSN; de Alencar LP; Cordeiro RA; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Lima DT; Paiva MAN; Monteiro AJ; Alves ND; Franco de Oliveira M; Sidrim JJC; Rocha MFG; Bandeira TJPG; Rodrigues TJS J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027 [TBL] [Abstract][Full Text] [Related]
38. Genetic Analysis of Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE mBio; 2019 Jan; 10(1):. PubMed ID: 30696744 [No Abstract] [Full Text] [Related]
39. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs. Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861 [TBL] [Abstract][Full Text] [Related]